About Myriad Genetics
Myriad Genetics is a company based in United States founded in 1991.. The company has 2,700 employees as of December 31, 2024. Myriad Genetics has completed 8 acquisitions, including Assurex Health, Counsyl and Crescendo Bioscience.
- Headquarter United States
- Employees 2700 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Myriad Genetics, Inc.
-
Annual Revenue
$837.6 M11.21as on Dec 31, 2024
-
Net Profit
$-127.3 M51.65as on Dec 31, 2024
-
EBITDA
$-26 M63.59as on Dec 31, 2024
-
Latest Funding Round
$249.39 K (USD), Post-IPO
Feb 12, 2019
- Investors
-
Employee Count
2700
as on Dec 31, 2024
-
Investments & Acquisitions
Assurex Health
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Myriad Genetics
Myriad Genetics is a publicly listed company on the NASDAQ with ticker symbol MYGN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Software Development Team
102 people
Sales and Marketing
100 people
Leadership Team
99 people
Senior Team
36 people
Data Analysis and Operations Team
26 people
Operations Team
16 people
Product Management Team
16 people
Legal and Compliance
14 people
Unlock access to complete
Funding Insights of Myriad Genetics
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $249,390
-
First Round
First Round
(29 Jun 2000)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Post-IPO - Myriad Genetics | Valuation |
investors |
|
| Jan, 2011 | Amount | Grant - Myriad Genetics | Valuation |
investors |
|
| Mar, 2010 | Amount | Grant - Myriad Genetics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Myriad Genetics
Myriad Genetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Myriad Genetics
Myriad Genetics has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Assurex Health, Counsyl and Crescendo Bioscience. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Fetal gender is identified via non-invasive genetic DNA testing.
|
2015 | ||||
|
Molecular breast cancer assays are developed for personalized treatment guidance.
|
2010 | ||||
|
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Myriad Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Myriad Genetics Comparisons
Competitors of Myriad Genetics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Myriad Genetics
Frequently Asked Questions about Myriad Genetics
When was Myriad Genetics founded?
Myriad Genetics was founded in 1991 and raised its 1st funding round 9 years after it was founded.
Where is Myriad Genetics located?
Myriad Genetics is headquartered in United States.
How many employees does Myriad Genetics have?
As of Dec 31, 2024, the latest employee count at Myriad Genetics is 2,700.
What is the annual revenue of Myriad Genetics?
Annual revenue of Myriad Genetics is $837.6M as on Dec 31, 2024.
What does Myriad Genetics do?
Molecular diagnostic tests for cancer risk assessment, disease diagnosis, progression evaluation, and treatment guidance are discovered and commercialized by Myriad Genetics, founded in 1991 in the United States. Operations span six major medical specialties, with products including Endopredict for breast cancer detection and Prolasis for prostate cancer. Diagnostic services for hereditary cancers and rheumatoid arthritis are also provided in the biotechnology sector.
Is Myriad Genetics publicly traded?
Yes, Myriad Genetics is publicly traded on NASDAQ under the ticker symbol MYGN.
How many acquisitions has Myriad Genetics made?
Myriad Genetics has made 8 acquisitions, including Assurex Health, Counsyl, and Crescendo Bioscience.
Who are Myriad Genetics's investors?
Myriad Genetics has 1 investor. Key investors include HHS.
What is Myriad Genetics's ticker symbol?
The ticker symbol of Myriad Genetics is MYGN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.